UK investor profile and portfolio
OrbiMed
2 UK company relationship(s) retained from funding evidence.
0 as lead
UK portfolio companies
- Charm TherapeuticsLondon
- MiroBioSouth East
Sources
- https://charmtx.com/charm-therapeutics-raises-80-million-in-series-b-financing-to-advance-development-of-best-in-class-menin-inhibitor-for-aml/
- https://www.eu-startups.com/2025/09/londons-charm-therapeutics-raises-e68-5-million-financing-to-tackle-treatment-resistant-cancers/
- https://www.biopharmadive.com/news/gilead-mirobio-deal-autoimmune/628941/
- https://www.ox.ac.uk/news/2022-08-04-oxford-spinout-mirobio-acquired-gilead-sciences-405m